These results illustrated that Ab@Tf-Cou6-PLGA NPs increased the apoptosis rate of cells from CML patients, and no significant effects were observed on cells from BCR/ABL negative donors. This evidence concerns the gene TF and chronic myelogenous leukemia, BCR-ABL1 positive.